1. Cancer‐associated fibroblasts predict poor outcome and promote periostin‐dependent invasion in oesophageal adenocarcinoma. Issue 3 (February 2015) Authors: Underwood, Timothy J; Hayden, Annette L; Derouet, Mathieu; Garcia, Edwin; Noble, Fergus; White, Michael J; Thirdborough, Steve; Mead, Abbie; Clemons, Nicholas; Mellone, Massimiliano; Uzoho, Chudy; Primrose, John N; Blaydes, Jeremy P; Thomas, Gareth J Journal: Journal of pathology Issue: Volume 235:Issue 3(2015) Page Start: 466 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Issue 5 (May 2019) Authors: Primrose, John N; Fox, Richard P; Palmer, Daniel H; Malik, Hassan Z; Prasad, Raj; Mirza, Darius; Anthony, Alan; Corrie, Pippa; Falk, Stephen; Finch-Jones, Meg; Wasan, Harpreet; Ross, Paul; Wall, Lucy; Wadsley, Jonathan; Evans, Jeff T R; Stocken, Deborah; Praseedom, Raaj; Ma, Yuk Ting; Davidson, B... Journal: Lancet oncology Issue: Volume 20:Issue 5(2019) Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Carcinoembryonic Antigen Monitoring to Detect Recurrence of Colorectal Cancer: How Should We Interpret the Test Results?. (1st December 2014) Authors: Shinkins, Bethany; Nicholson, Brian D; James, Timothy J; Primrose, John N; Mant, David Journal: Clinical chemistry Issue: Volume 60:Number 12(2014) Page Start: 1572 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hepatic metastases resection after cetuximab: are we missing something? – Authors' reply. Issue 5 (May 2020) Authors: Pugh, Sian A; Bridgewater, John A; Primrose, John N Journal: Lancet oncology Issue: Volume 21:Issue 5(2020) Page Start: e229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial. Issue 3 (March 2020) Authors: Bridgewater, John A; Pugh, Siân A; Maishman, Tom; Eminton, Zina; Mellor, Jane; Whitehead, Amy; Stanton, Louise; Radford, Michael; Corkhill, Andrea; Griffiths, Gareth O; Falk, Stephen; Valle, Juan W; O'Reilly, Derek; Siriwardena, Ajith K; Hornbuckle, Joanne; Rees, Myrddin; Iveson, Timothy J; Hicki... Journal: Lancet oncology Issue: Volume 21:Issue 3(2020) Page Start: 398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis. Issue 6 (24th March 2015) Authors: Ling, Hui; Pickard, Karen; Ivan, Cristina; Isella, Claudio; Ikuo, Mariko; Mitter, Richard; Spizzo, Riccardo; Bullock, Marc D; Braicu, Cornelia; Pileczki, Valentina; Vincent, Kimberly; Pichler, Martin; Stiegelbauer, Verena; Hoefler, Gerald; Almeida, Maria I; Hsiao, Annie; Zhang, Xinna; Primrose, J... Journal: Gut Issue: Volume 65:Issue 6(2016) Page Start: 977 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗